Adimab, LLC
7 Lucent Drive
Lebanon
New Hampshire
03766
United States
Tel: 603.643.7110
Website: http://www.adimab.com/
Email: info@adimab.com
70 articles about Adimab, LLC
-
Adimab Provides Year-End Update on 2018 Partnership Activities
1/8/2019
- Added 17 Partnerships - - Achieved 70 Milestones - - Total of Over 260 Therapeutic Programs at End of 2018
-
Adimab Partner Innovent Receives Product Approval for PD-1 Antibody for Hodgkin's Lymphoma
1/7/2019
First Adimab Antibody to Enter the Market
-
Adimab Initiates Update on Clinical Progression of Partner Programs
1/11/2018
Adimab announced that six new partner programs entered clinical trials in 2017.
-
Adimab Announces Antibody Discovery Collaboration with Boehringer Ingelheim
1/10/2018
Under the terms of the agreement, Adimab will use its proprietary platform to discover and optimize antibodies against targets chosen by BI, who will have the rights to develop and commercialize therapeutic programs resulting from the collaboration.
-
Adimab Provides Year-End Update on 2017 Partnership Activities
1/8/2018
Adimab today announced that in 2017 it entered into agreements with seven new companies.
-
Adimab LLC. Announces Platform Transfer With Eli Lilly
7/18/2017
-
Adimab LLC. Provides Mid-Year Update On 2017 Partnership Activity
6/21/2017
-
Arsanis And Adimab LLC. Enter Into License Agreement To Target Respiratory Syncytial Virus (RSV) With Monoclonal Antibodies
2/27/2017
-
Adimab LLC. Publishes Biophysical Performance Metrics That Predict Drug-Like Properties Of Antibody-Based Therapeutics
2/23/2017
-
Adimab LLC. Scientists Report The Isolation Of Highly Potent anti-RSV Antibodies
12/12/2016
-
Innovent Biologics Expands Adimab LLC. Partnership; Second mAb Partnership In A Week
6/13/2016
-
Adimab LLC. And Innovent Biologics Expand Partnership For The Discovery Of Antibodies And Bispecifics
6/7/2016
-
Adimab LLC. Announces Two New Partnerships And Commercial Licenses With Eli Lilly, Kite Pharma And Jounce
4/27/2016
-
Adimab LLC. Announces Antibody Discovery Collaboration With Takeda
4/26/2016
-
Adimab LLC. Expands Bispecific Antibody Offering With Novel CD3 Program
4/25/2016
-
Adimab LLC. Scientists Report The Isolation Of Highly Potent Anti-Ebola Virus Antibodies From Recent Zaire Outbreak
2/19/2016
-
Adimab LLC. Announces Technology Transfer Agreement With Merck & Co.
1/12/2016
-
Adimab LLC. Provides Update On Recent Partnerships And Milestones
1/11/2016
-
Adimab LLC. Provides Update On Recent Partnerships And Milestones
1/11/2016
-
Adimab LLC. Establishes Antibody Discovery Collaborations With MD Anderson Cancer Center And Memorial Sloan-Kettering Cancer Center
12/8/2015